{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:51:33Z","timestamp":1771462293043,"version":"3.50.1"},"reference-count":16,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2009,10,22]],"date-time":"2009-10-22T00:00:00Z","timestamp":1256169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2009,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Porphyria cutanea tarda (PCT) is regularly associated with changes in liver tissue. On the other hand, systematic investigations are lacking on whether there is a correlation between the severity of liver damage and chloroquine treatment.<\/jats:p><jats:p><jats:bold>Patients and methods\u2002<\/jats:bold> During a 20\u2010year period, liver biopsies were obtained in 89 patients with PCT confirmed by biochemical analysis of urine and feces and low\u2010dose chloroquine therapy. Seventeen patients with alcohol\u2010induced liver disease were excluded. In 8 of 63 patients, only a single biopsy was available. Classification of liver damage was performed according to the Riedel score. Electron microscopy was available from 24 patients. In a second group of patients, the HFE status was investigated and Berlin blue stains of liver biopsies were performed.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> There was no correlation between the duration of cutaneous symptoms and liver pathology. After 12\u2003months chloroquine treatment, 45 patients (81%) disclosed an improvement of liver pathology, nine (16%) had no change, and a worsening was observed in one patient (3%). All patients achieved a complete clinical and biochemical remission. In 13 of 16 patients with a relapse, there was again a deterioration of liver damage. Patients with HFE mutations had a significant higher risk (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05) for hepatic siderosis.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> The severity of liver damage was not correlated with the disease duration. Chloroquine treatment resulted in PCT remission (clinical and biochemical) and in 81% to an improvement of liver morphology.<\/jats:p>","DOI":"10.1111\/j.1365-4632.2009.04205.x","type":"journal-article","created":{"date-parts":[[2009,10,22]],"date-time":"2009-10-22T10:08:11Z","timestamp":1256206091000},"page":"1250-1253","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Does chloroquine therapy of porphyria cutanea tarda influence liver pathology?"],"prefix":"10.1111","volume":"48","author":[{"given":"U","family":"Wollina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"K\u00f6stler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U","family":"St\u00f6lzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,10,22]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.139.3.309"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08693.x"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i35.4673"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(95)80004-2"},{"key":"e_1_2_5_6_2","first-page":"2103","volume-title":"The Molecular Basis of Inherited Disease","author":"Kappas A","year":"1995"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1974.tb06367.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2007.00131.x"},{"key":"e_1_2_5_9_2","first-page":"1030","article-title":"Iron metabolism and chloroquine phosphate therapy in porphyria cutanea tarda [German]","volume":"65","author":"K\u00f6stler E","year":"1990","journal-title":"Z Hautkr"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1971.tb04337.x"},{"key":"e_1_2_5_11_2","first-page":"216","article-title":"Zur Morphologie des Leberschadens bei der chronischen hepatischen Porphyrie unter besonderer Ber\u00fccksichtigung des Therapieeffektes","volume":"5","author":"Riedel H","year":"1984","journal-title":"Pathologe"},{"key":"e_1_2_5_12_2","first-page":"253","article-title":"Zur Bedeutung parakristalliner Nadelstrukturen f\u00fcr die Diagnose der chronischen hepatischen Porphyrie \u2013 licht\u2010 und elektronenmikroskopische Untersuchungen an Biopsiematerial","volume":"127","author":"Kemmer C","year":"1983","journal-title":"Zentralbl Allg Pathol"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004280100401"},{"key":"e_1_2_5_14_2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2340\/00015555-0472","article-title":"Measurement of liver iron content by magnetic resonance imaging in 20 patients with overt porphyria cutanea tarda before phlebotomy therapy: a prospective study","volume":"88","author":"Dereure O","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0260"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.6.3.377"},{"key":"e_1_2_5_17_2","first-page":"135","article-title":"Frequency of occurrence of hepatocellular carcinoma in patients with porphyria cutanea tarda in long\u2010term follow\u2010up","volume":"19","author":"Kordac V","year":"1972","journal-title":"Neoplasma"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-4632.2009.04205.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-4632.2009.04205.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T01:41:15Z","timestamp":1697334075000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-4632.2009.04205.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10,22]]},"references-count":16,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["10.1111\/j.1365-4632.2009.04205.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-4632.2009.04205.x","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,22]]},"assertion":[{"value":"2009-10-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}